Ocular Therapeutix Inc (OCUL)
6.29
+0.12
(+1.94%)
USD |
NASDAQ |
May 20, 16:00
6.28
-0.01
(-0.16%)
After-Hours: 20:00
Ocular Therapeutix Total Liabilities (Quarterly): 130.96M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 130.96M |
December 31, 2023 | 160.93M |
September 30, 2023 | 154.53M |
June 30, 2023 | 119.47M |
March 31, 2023 | 118.86M |
December 31, 2022 | 113.91M |
September 30, 2022 | 112.35M |
June 30, 2022 | 107.27M |
March 31, 2022 | 107.83M |
December 31, 2021 | 116.89M |
September 30, 2021 | 130.40M |
June 30, 2021 | 150.46M |
March 31, 2021 | 159.63M |
December 31, 2020 | 185.77M |
September 30, 2020 | 102.34M |
June 30, 2020 | 101.92M |
March 31, 2020 | 83.52M |
December 31, 2019 | 82.37M |
September 30, 2019 | 77.41M |
June 30, 2019 | 81.48M |
March 31, 2019 | 75.84M |
Date | Value |
---|---|
December 31, 2018 | 37.17M |
September 30, 2018 | 24.75M |
June 30, 2018 | 24.73M |
March 31, 2018 | 27.50M |
December 31, 2017 | 29.28M |
September 30, 2017 | 28.48M |
June 30, 2017 | 31.65M |
March 31, 2017 | 26.79M |
December 31, 2016 | 22.93M |
September 30, 2016 | 20.05M |
June 30, 2016 | 19.45M |
March 31, 2016 | 20.26M |
December 31, 2015 | 20.72M |
September 30, 2015 | 20.51M |
June 30, 2015 | 20.36M |
March 31, 2015 | 19.42M |
December 31, 2014 | 19.50M |
September 30, 2014 | 18.28M |
June 30, 2014 | 93.41M |
March 31, 2014 | 3.933M |
December 31, 2013 | 78.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
77.41M
Minimum
Sep 2019
185.77M
Maximum
Dec 2020
119.92M
Average
115.40M
Median
Total Liabilities (Quarterly) Benchmarks
Amgen Inc | 87.96B |
Assertio Holdings Inc | 147.47M |
CytomX Therapeutics Inc | 216.37M |
EyePoint Pharmaceuticals Inc | 79.31M |
Cormedix Inc | 10.01M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 538.95M |
Shareholders Equity (Quarterly) | 407.98M |
Debt to Equity Ratio | 0.1629 |
Current Ratio | 21.39 |
Net Debt Paydown Yield | -0.18% |